SGK1 inhibitor compounds and their use for the treatment of neurodegenerative and / or cardiovascular diseases

CA3330167A1Pending Publication Date: 2026-11-05CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3330167
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-22
Filing Date
2025-05-22
Publication Date
2026-11-05
Patent Text Reader

Abstract

The present invention relates to a series of compounds with an indazole structural core, which are capable of inhibiting the SGK1 enzyme. Accordingly, the invention also relates to the use of these compounds to treat neurodegenerative and / or cardiovascular diseases involving this enzyme, such as Parkinson's disease, Alzheimer's disease, myocardial infarction or high blood pressure.
Need to check novelty before this filing date? Find Prior Art